NYLIM
ABBV icon

New York Life Investment Management’s AbbVie ABBV Stock Holding History

New York Life Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62M Buy
246,242
+749
+0.3% +$161K 0.43% 46
2026
Q1 		$53.4M Buy
245,493
+3,176
+1% +$705K 0.45% 38
2025
Q4 		$55.4M Buy
242,317
+2,418
+1% +$551K 0.48% 35
2025
Q3 		$55.5M Sell
239,899
-1,409
-0.6% -$287K 0.49% 38
2025
Q2 		$44.8M Buy
241,308
+3,879
+2% +$721K 0.42% 42
2025
Q1 		$49.7M Sell
237,429
-828
-0.3% -$161K 0.51% 36
2024
Q4 		$42.3M Buy
238,257
+2,072
+0.9% +$381K 0.41% 42
2024
Q3 		$46.6M Sell
236,185
-7,474
-3% -$1.39M 0.45% 39
2024
Q2 		$41.8M Buy
243,659
+1,345
+0.6% +$223K 0.42% 38
2024
Q1 		$44.1M Sell
242,314
-9,304
-4% -$1.6M 0.44% 41
2023
Q4 		$39M Sell
251,618
-17,093
-6% -$2.49M 0.4% 46
2023
Q3 		$40.1M Sell
268,711
-319
-0.1% -$46.8K 0.43% 41
2023
Q2 		$36.2M Buy
269,030
+61
+0% +$8.95K 0.38% 46
2023
Q1 		$42.9M Sell
268,969
-1,071
-0.4% -$164K 0.48% 38
2022
Q4 		$43.6M Sell
270,040
-177
-0.1% -$27.1K 0.5% 35
2022
Q3 		$36.3M Sell
270,217
-762
-0.3% -$109K 0.44% 39
2022
Q2 		$41.5M Buy
+270,979
New +$41.4M 0.48% 35
2015
Q4 		– Sell
-11,412
Closed -$621K – 54
2015
Q3 		$621K Buy
11,412
+551
+5% +$35.9K 0.06% 74
2015
Q2 		$730K Buy
10,861
+895
+9% +$58.4K 0.08% 68
2015
Q1 		$583K Hold
9,966
– – 0.07% 77
2014
Q4 		$652K Sell
9,966
-2,917
-23% -$184K 0.08% 79
2014
Q3 		$744K Hold
12,883
– – 0.12% 57
2014
Q2 		$727K Buy
+12,883
New +$676K 0.12% 59

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

New York Life Investment Management's ABBV Position: Q2 2026 in Review

New York Life Investment Management increased its AbbVie (ABBV) stake by 0.31% in Q2 2026, buying an estimated $161K and bringing the position to 246,242 shares worth $62M. The position accounts for 0.43% of the portfolio, ranked #46.

New York Life Investment Management first reported a position in ABBV in Q2 2014 and has held it in 23 quarters since. 2,976 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New York Life Investment Management held 246,242 shares of AbbVie worth $62M as of Q2 2026.
  • New York Life Investment Management bought 749 AbbVie shares in Q2 2026, an estimated $161K.
  • AbbVie made up 0.43% of New York Life Investment Management's portfolio in Q2 2026, its #46 holding.
  • New York Life Investment Management first reported a position in AbbVie in Q2 2014 and has held it in 23 quarters since.
  • 2,976 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.